Report Detail

The need for artificial pancreas devices systems to mimic the function of a healthy pancreas will induce vendors to focus on the adoption of advanced technologies. Vendors have already started integrating their artificial pancreas devices systems (APDS) with several sensors, software, and related algorithms to ensure the effective functioning of APDS. For instance,
One of the major trends that will gain traction in this market is the increasing demand for remote monitoring applications. The growing need for home healthcare monitoring will drive the need for remote patient monitoring systems in the APDS market as well. This will induce vendors to develop an effective remote monitoring system for the treatment of diabetes with APDS. Several closed loop systems including Inreda's artificial pancreas, Bionic pancreas, GlucoSitter, Florence, Diabetes Assistant, and Closed Loop Glucose-Sensing Insulin Delivery System are already being tested for remote monitoring applications.
In 2019, the market size of Artificial Pancreas Devices System is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Artificial Pancreas Devices System.

This report studies the global market size of Artificial Pancreas Devices System, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Artificial Pancreas Devices System production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
Medtronic
Johnson & Johnson
Insulet
Tandem Diabetes Care
Roche
Beta Bionics
Bigfoot Biomedical
Cellnovo
Dexcom
Dose Safety
DreaMed Diabetes
Inreda Diabetic

Market Segment by Product Type
Threshold Suspend Device System
Non-Threshold Suspend Device System (NTSDS)
Control to Range System (CTRS)
Control to Target System (CTTS)

Market Segment by Application
Hospitals
Clinics
Other

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Artificial Pancreas Devices System status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Artificial Pancreas Devices System manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Artificial Pancreas Devices System are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025


Table of Contents

    1 Report Overview

    • 1.1 Research Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Artificial Pancreas Devices System Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Threshold Suspend Device System
      • 1.3.3 Non-Threshold Suspend Device System (NTSDS)
      • 1.3.4 Control to Range System (CTRS)
      • 1.3.5 Control to Target System (CTTS)
    • 1.4 Market Segment by Application
      • 1.4.1 Global Artificial Pancreas Devices System Market Share by Application (2019-2025)
      • 1.4.2 Hospitals
      • 1.4.3 Clinics
      • 1.4.4 Other
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Production and Capacity Analysis
      • 2.1.1 Global Artificial Pancreas Devices System Production Value 2014-2025
      • 2.1.2 Global Artificial Pancreas Devices System Production 2014-2025
      • 2.1.3 Global Artificial Pancreas Devices System Capacity 2014-2025
      • 2.1.4 Global Artificial Pancreas Devices System Marketing Pricing and Trends
    • 2.2 Key Producers Growth Rate (CAGR) 2019-2025
      • 2.2.1 Global Artificial Pancreas Devices System Market Size CAGR of Key Regions
      • 2.2.2 Global Artificial Pancreas Devices System Market Share of Key Regions
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Capacity and Production by Manufacturers
      • 3.1.1 Global Artificial Pancreas Devices System Capacity by Manufacturers
      • 3.1.2 Global Artificial Pancreas Devices System Production by Manufacturers
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Artificial Pancreas Devices System Revenue by Manufacturers (2014-2019)
      • 3.2.2 Artificial Pancreas Devices System Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Artificial Pancreas Devices System Market Concentration Ratio (CR5 and HHI)
    • 3.3 Artificial Pancreas Devices System Price by Manufacturers
    • 3.4 Key Manufacturers Artificial Pancreas Devices System Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Artificial Pancreas Devices System Market
    • 3.6 Key Manufacturers Artificial Pancreas Devices System Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Production and Production Value for Each Type
      • 4.1.1 Threshold Suspend Device System Production and Production Value (2014-2019)
      • 4.1.2 Non-Threshold Suspend Device System (NTSDS) Production and Production Value (2014-2019)
      • 4.1.3 Control to Range System (CTRS) Production and Production Value (2014-2019)
      • 4.1.4 Control to Target System (CTTS) Production and Production Value (2014-2019)
    • 4.2 Global Artificial Pancreas Devices System Production Market Share by Type
    • 4.3 Global Artificial Pancreas Devices System Production Value Market Share by Type
    • 4.4 Artificial Pancreas Devices System Ex-factory Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Artificial Pancreas Devices System Consumption by Application

    6 Production by Regions

    • 6.1 Global Artificial Pancreas Devices System Production (History Data) by Regions 2014-2019
    • 6.2 Global Artificial Pancreas Devices System Production Value (History Data) by Regions
    • 6.3 United States
      • 6.3.1 United States Artificial Pancreas Devices System Production Growth Rate 2014-2019
      • 6.3.2 United States Artificial Pancreas Devices System Production Value Growth Rate 2014-2019
      • 6.3.3 Key Players in United States
      • 6.3.4 United States Artificial Pancreas Devices System Import & Export
    • 6.4 European Union
      • 6.4.1 European Union Artificial Pancreas Devices System Production Growth Rate 2014-2019
      • 6.4.2 European Union Artificial Pancreas Devices System Production Value Growth Rate 2014-2019
      • 6.4.3 Key Players in European Union
      • 6.4.4 European Union Artificial Pancreas Devices System Import & Export
    • 6.5 China
      • 6.5.1 China Artificial Pancreas Devices System Production Growth Rate 2014-2019
      • 6.5.2 China Artificial Pancreas Devices System Production Value Growth Rate 2014-2019
      • 6.5.3 Key Players in China
      • 6.5.4 China Artificial Pancreas Devices System Import & Export
    • 6.6 Rest of World
      • 6.6.1 Japan
      • 6.6.2 Korea
      • 6.6.3 India
      • 6.6.4 Southeast Asia

    7 Artificial Pancreas Devices System Consumption by Regions

    • 7.1 Global Artificial Pancreas Devices System Consumption (History Data) by Regions
    • 7.2 United States
      • 7.2.1 United States Artificial Pancreas Devices System Consumption by Type
      • 7.2.2 United States Artificial Pancreas Devices System Consumption by Application
    • 7.3 European Union
      • 7.3.1 European Union Artificial Pancreas Devices System Consumption by Type
      • 7.3.2 European Union Artificial Pancreas Devices System Consumption by Application
    • 7.4 China
      • 7.4.1 China Artificial Pancreas Devices System Consumption by Type
      • 7.4.2 China Artificial Pancreas Devices System Consumption by Application
    • 7.5 Rest of World
      • 7.5.1 Rest of World Artificial Pancreas Devices System Consumption by Type
      • 7.5.2 Rest of World Artificial Pancreas Devices System Consumption by Application
      • 7.5.1 Japan
      • 7.5.2 Korea
      • 7.5.3 India
      • 7.5.4 Southeast Asia

    8 Company Profiles

    • 8.1 Medtronic
      • 8.1.1 Medtronic Company Details
      • 8.1.2 Company Description and Business Overview
      • 8.1.3 Production and Revenue of Artificial Pancreas Devices System
      • 8.1.4 Artificial Pancreas Devices System Product Introduction
      • 8.1.5 Medtronic Recent Development
    • 8.2 Johnson & Johnson
      • 8.2.1 Johnson & Johnson Company Details
      • 8.2.2 Company Description and Business Overview
      • 8.2.3 Production and Revenue of Artificial Pancreas Devices System
      • 8.2.4 Artificial Pancreas Devices System Product Introduction
      • 8.2.5 Johnson & Johnson Recent Development
    • 8.3 Insulet
      • 8.3.1 Insulet Company Details
      • 8.3.2 Company Description and Business Overview
      • 8.3.3 Production and Revenue of Artificial Pancreas Devices System
      • 8.3.4 Artificial Pancreas Devices System Product Introduction
      • 8.3.5 Insulet Recent Development
    • 8.4 Tandem Diabetes Care
      • 8.4.1 Tandem Diabetes Care Company Details
      • 8.4.2 Company Description and Business Overview
      • 8.4.3 Production and Revenue of Artificial Pancreas Devices System
      • 8.4.4 Artificial Pancreas Devices System Product Introduction
      • 8.4.5 Tandem Diabetes Care Recent Development
    • 8.5 Roche
      • 8.5.1 Roche Company Details
      • 8.5.2 Company Description and Business Overview
      • 8.5.3 Production and Revenue of Artificial Pancreas Devices System
      • 8.5.4 Artificial Pancreas Devices System Product Introduction
      • 8.5.5 Roche Recent Development
    • 8.6 Beta Bionics
      • 8.6.1 Beta Bionics Company Details
      • 8.6.2 Company Description and Business Overview
      • 8.6.3 Production and Revenue of Artificial Pancreas Devices System
      • 8.6.4 Artificial Pancreas Devices System Product Introduction
      • 8.6.5 Beta Bionics Recent Development
    • 8.7 Bigfoot Biomedical
      • 8.7.1 Bigfoot Biomedical Company Details
      • 8.7.2 Company Description and Business Overview
      • 8.7.3 Production and Revenue of Artificial Pancreas Devices System
      • 8.7.4 Artificial Pancreas Devices System Product Introduction
      • 8.7.5 Bigfoot Biomedical Recent Development
    • 8.8 Cellnovo
      • 8.8.1 Cellnovo Company Details
      • 8.8.2 Company Description and Business Overview
      • 8.8.3 Production and Revenue of Artificial Pancreas Devices System
      • 8.8.4 Artificial Pancreas Devices System Product Introduction
      • 8.8.5 Cellnovo Recent Development
    • 8.9 Dexcom
      • 8.9.1 Dexcom Company Details
      • 8.9.2 Company Description and Business Overview
      • 8.9.3 Production and Revenue of Artificial Pancreas Devices System
      • 8.9.4 Artificial Pancreas Devices System Product Introduction
      • 8.9.5 Dexcom Recent Development
    • 8.10 Dose Safety
      • 8.10.1 Dose Safety Company Details
      • 8.10.2 Company Description and Business Overview
      • 8.10.3 Production and Revenue of Artificial Pancreas Devices System
      • 8.10.4 Artificial Pancreas Devices System Product Introduction
      • 8.10.5 Dose Safety Recent Development
    • 8.11 DreaMed Diabetes
    • 8.12 Inreda Diabetic

    9 Market Forecast

    • 9.1 Global Market Size Forecast
      • 9.1.1 Global Artificial Pancreas Devices System Capacity, Production Forecast 2019-2025
      • 9.1.2 Global Artificial Pancreas Devices System Production Value Forecast 2019-2025
    • 9.2 Market Forecast by Regions
      • 9.2.1 Global Artificial Pancreas Devices System Production and Value Forecast by Regions 2019-2025
      • 9.2.2 Global Artificial Pancreas Devices System Consumption Forecast by Regions 2019-2025
    • 9.3 United States
      • 9.3.1 Production and Value Forecast in United States
      • 9.3.2 Consumption Forecast in United States
    • 9.4 European Union
      • 9.4.1 Production and Value Forecast in European Union
      • 9.4.2 Consumption Forecast in European Union
    • 9.5 China
      • 9.5.1 Production and Value Forecast in China
      • 9.5.2 Consumption Forecast in China
    • 9.6 Rest of World
      • 9.6.1 Japan
      • 9.6.2 Korea
      • 9.6.3 India
      • 9.6.4 Southeast Asia
    • 9.7 Forecast by Type
      • 9.7.1 Global Artificial Pancreas Devices System Production Forecast by Type
      • 9.7.2 Global Artificial Pancreas Devices System Production Value Forecast by Type
    • 9.8 Consumption Forecast by Application

    10 Value Chain and Sales Channels Analysis

    • 10.1 Value Chain Analysis
    • 10.2 Sales Channels Analysis
      • 10.2.1 Artificial Pancreas Devices System Sales Channels
      • 10.2.2 Artificial Pancreas Devices System Distributors
    • 10.3 Artificial Pancreas Devices System Customers

    11 Opportunities & Challenges, Threat and Affecting Factors

    • 11.1 Market Opportunities
    • 11.2 Market Challenges
    • 11.3 Porter's Five Forces Analysis

    12 Key Findings

      13 Appendix

      • 13.1 Research Methodology
        • 13.1.1 Methodology/Research Approach
          • 13.1.1.1 Research Programs/Design
          • 13.1.1.2 Market Size Estimation
          • 13.1.1.3 Market Breakdown and Data Triangulation
        • 13.1.2 Data Source
          • 13.1.2.1 Secondary Sources
          • 13.1.2.2 Primary Sources
      • 13.2 Author Details

      Summary:
      Get latest Market Research Reports on Artificial Pancreas Devices System. Industry analysis & Market Report on Artificial Pancreas Devices System is a syndicated market report, published as Global (United States, European Union and China) Artificial Pancreas Devices System Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Artificial Pancreas Devices System market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,280.00
      $4,920.00
      $6,560.00
      2,528.88
      3,793.32
      5,057.76
      3,037.28
      4,555.92
      6,074.56
      502,627.20
      753,940.80
      1,005,254.40
      276,602.40
      414,903.60
      553,204.80
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report